4 citations
,
July 2024 in “Pharmacology Research & Perspectives” Ritlecitinib is safe and may effectively treat alopecia areata.
8 citations
,
April 1991 in “European journal of endocrinology” 3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.
February 1980 in “PubMed” May 2013 in “Springer eBooks” January 2009 in “Springer eBooks” 21 citations
,
December 2014 in “Clinics in dermatology” Squaric acid dibutylester effectively treats alopecia areata.
September 2024 in “Journal of the American Academy of Dermatology” Hair loss significantly affects the quality of life for Muslim American women, especially those not wearing hijab.
June 2024 in “Journal of Clinical Oncology” Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.
Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.
February 2025 in “BioNanoScience”
July 2025 in “Journal of Investigative Dermatology” AMP-303 safely increases hair growth in men with hair loss.
51 citations
,
March 2022 in “Frontiers in Immunology” Alarmin cytokines are key in controlling skin immunity and inflammation.
2 citations
,
April 2025 in “Dermatology and Therapy” Alopecia areata affects quality of life more in adolescents than adults.
Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.
4 citations
,
December 2012 in “PubMed” January 2026 in “Annals of Dermatology” Alitretinoin may help treat mild to moderate alopecia areata.
17 citations
,
August 2002 in “Dermatologic Surgery” Fluridil safely promotes hair growth in men with androgenetic alopecia.
April 2023 in “Journal of Investigative Dermatology” A new treatment for hair loss shows promise with fewer side effects.
September 2020 in “Annals of Punjab Medical College” Alopecia areata in children is more common in boys, mainly affects the scalp, and is linked to genetics and psoriasis.
September 2024 in “Health of Man” Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.
December 2025 in “Journal of health economics and outcomes research” Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.
25 citations
,
November 2022 in “British journal of dermatology/British journal of dermatology, Supplement” Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.
6 citations
,
January 2008 in “PubMed”
November 2024 in “Skin Appendage Disorders” Start low-dose minoxidil gradually, especially for women, to reduce side effects.
April 2023 in “Journal of Investigative Dermatology” Alopecia areata significantly affects emotional well-being and quality of life, especially in younger adults.
1 citations
,
September 2023 in “Journal of the American Academy of Dermatology” Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.
June 2023 in “Diyala Journal of Medicine” Alopecia areata is common in young males and linked to stress.
3 citations
,
January 1992 in “Gynecological Endocrinology” 3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.